Adalimumab – blockbuster & never ending story
Resolved patent disputes With Abbvie and Alvotech having solved their patent disputes, market entry for new biosimilars for adalimumab applicable for various indications might speed up. The patent protection of the originator product Humira ® has expired in the EU in 2017, though due to complex patent claim development and market launch of non-component material
... Continued